Stay up-to-date with the latest happenings in the rapidly evolving field of In Vitro Diagnostics (IVD) in China.

As of April 30, 2025, there are 82 publicly listed companies in China engaged in the in vitro diagnostics (IVD) industry. Among them, 61 companies focus primarily on IVD, while 21 have IVD as part of their broader business portfolios.

Illumina and Beckman Coulter Life Sciences said on Tuesday that they have partnered on application development for the Biomek NGenius next-generation library preparation system.

On the evening of February 18, Shenzhen YHLO Biotech Co., Ltd. announced that it received a purchase order from the Institute of Medical Biology Co., Ltd.. According to the purchase order, MBL will purchase antigen test kits from the YHLO, the total amount is approximately CNY 316 million.

British testing firm DnaNudge announced on Wednesday that it has partnered with Pantonic Health to launch its CovidNudge test in Australia.

Diagnostics manufacturer Quidel reported after the close of the market on Thursday that its fourth quarter revenues fell more than 21 percent year over year due primarily to shift in product mix and decreased COVID-19 product sales.

While the word “mutation” may conjure up alarming notions, a mutation in brain immune cells serves a positive role in protecting people against Alzheimer’s disease.

Diagnostics manufacturer Quidel reported after the close of the market on Thursday that its fourth quarter revenues fell more than 21 percent year over year due primarily to shift in product mix and decreased COVID-19 product sales.

On February 17, 2022, Roche Diagnostics China announced in Shanghai that it had reached a strategic partnership with Sanomede Medical Technology Co., Ltd. (hereinafter referred to as "Sanomede") to jointly launch a new RS600 Lab Automation System (LAS) for Chinese market.

Recently, Hong Kong has been hit by the epidemic continuously. On February 16, Kang Keren, senior vice president of Wondfo Biotech, said that in response to the epidemic in Hong Kong, Wondfo's "Anti-epidemic pioneer" is preparing to go to the front line and guarantee supply.

The European Union’s In Vitro Diagnostics Regulation (IVDR) is set to take effect May 26, 2022, but a recent effort to amend the transitional provisions of the new regulation may bring some relief.

Thermo Fisher Scientific's solution for cell and gene therapies involves a combination of cold chain logistics, serialization compliance, and distribution